ResearcherHeidelberg UniversityNo recent work listed
Stefan Rieken
Matched on ORCID iD 0009-0000-7018-2856; OpenAlex author ID A5080547151. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2012: 1 paper · 2013: 2 papers · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 6
- Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy. Co-author DOI 10.3390/cancers14051301↗
- Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line. Last author DOI 10.1038/s41598-020-57456-2↗
- Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma. Co-author DOI 10.1186/s12957-015-0560-3↗
- In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines. Co-author DOI 10.1093/jrr/rrt052↗
- Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection. Co-author DOI 10.1186/1748-717x-8-27↗
- Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Co-author DOI 10.1186/1748-717x-7-28↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jürgen Debus · 5 shared papers, 2012–2020 · strength 0.26
- Paper Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line. DOI 10.1038/s41598-020-57456-2↗
- Paper Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma. DOI 10.1186/s12957-015-0560-3↗
- Paper In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic … DOI 10.1093/jrr/rrt052↗
- Hannah Flebbe · 1 shared paper, 2022 · strength 0.16
- Marian Grade · 1 shared paper, 2022 · strength 0.16
- Β. Michael Ghadimi · 1 shared paper, 2022 · strength 0.16
- Jochen Gaedcke · 1 shared paper, 2022 · strength 0.16
- Günter Schneider · 1 shared paper, 2022 · strength 0.16
- Alexander Otto König · 1 shared paper, 2022 · strength 0.16
- Stephanie Elisabeth Combs · 4 shared papers, 2012–2015 · strength 0.15
- Paper Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma. DOI 10.1186/s12957-015-0560-3↗
- Paper In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic … DOI 10.1093/jrr/rrt052↗
- Paper Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-res… DOI 10.1186/1748-717x-8-27↗
- Daniel Habermehl · 4 shared papers, 2012–2015 · strength 0.15
- Paper Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma. DOI 10.1186/s12957-015-0560-3↗
- Paper In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic … DOI 10.1093/jrr/rrt052↗
- Paper Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-res… DOI 10.1186/1748-717x-8-27↗
- Rienk Offringa · 1 shared paper, 2020 · strength 0.11
- Philipp Schröter · 1 shared paper, 2020 · strength 0.11
- Markus Wolfgang Büchler · 3 shared papers, 2012–2015 · strength 0.11
- Paper Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma. DOI 10.1186/s12957-015-0560-3↗
- Paper Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-res… DOI 10.1186/1748-717x-8-27↗
- Paper Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. DOI 10.1186/1748-717x-7-28↗
- Jens Werner · 3 shared papers, 2012–2015 · strength 0.11
- Paper Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma. DOI 10.1186/s12957-015-0560-3↗
- Paper Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-res… DOI 10.1186/1748-717x-8-27↗
- Paper Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. DOI 10.1186/1748-717x-7-28↗
- Dirk Jäger · 1 shared paper, 2015 · strength 0.05
- Christoph Springfeld · 1 shared paper, 2015 · strength 0.05
- Andrea Mairani · 1 shared paper, 2013 · strength 0.03
- Rami Ateyah El Shafie · 1 shared paper, 2013 · strength 0.03
- Kerstin Anne Kessel · 1 shared paper, 2012 · strength 0.03
- Jürgen Weitz · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.